Literature DB >> 12577309

Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells.

Paola Strocchi1, Annalisa Pession, Barbara Dozza.   

Abstract

Cdk5, a member of the cyclin-dependent kinase (cdk) family, is predominantly active in neurons, where its activity is tightly regulated by the binding of its neuronal activators p35 and p39. Cdk5 is implicated in regulating the proper neuronal function; a deregulation of cdk5 has been found associated with Alzheimer's disease and amyotrophic lateral sclerosis. As oxidative stress products have been seen co-localized with pathological hallmarks of neurodegenerative diseases, we studied the effect of oxidative stress on the cdk5 enzyme in human neuroblastoma IMR-32 cells. We evaluated the effects of 4-hydroxynonenal and Ascorbate plus FeSO(4) on cdk5 activity and on the expression of cdk5 and p35 proteins. We report here that oxidative stress stimulates cdk5 activity and induces an upregulation of its regulatory and catalytic subunit expression in IMR-32 vital cells, showing that the cdk5 enzyme is involved in the signaling pathway activated by oxidative stress. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12577309     DOI: 10.1002/jcb.10391

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.

Authors:  Jing Qu; Tomohiro Nakamura; Emily A Holland; Scott R McKercher; Stuart A Lipton
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

3.  A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.

Authors:  Cecilia M Sahlgren; Hanna-Mari Pallari; Tao He; Ying-Hao Chou; Robert D Goldman; John E Eriksson
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

4.  S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.

Authors:  Jing Qu; Tomohiro Nakamura; Gang Cao; Emily A Holland; Scott R McKercher; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Increased accumbens Cdk5 expression in rats after short-access to self-administered cocaine, but not after long-access sessions.

Authors:  Andrew P Seiwell; Maria E Reveron; Christine L Duvauchelle
Journal:  Neurosci Lett       Date:  2007-02-20       Impact factor: 3.046

6.  TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity.

Authors:  B K Binukumar; Ya-Li Zheng; Varsha Shukla; Niranjana D Amin; Philip Grant; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.

Authors:  Nicholas C Turner; Christopher J Lord; Elizabeth Iorns; Rachel Brough; Sally Swift; Richard Elliott; Sydonia Rayter; Andrew N Tutt; Alan Ashworth
Journal:  EMBO J       Date:  2008-04-03       Impact factor: 11.598

Review 8.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

9.  Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.

Authors:  Susan A Austin; Zvonimir S Katusic
Journal:  Circ Res       Date:  2016-09-06       Impact factor: 17.367

10.  Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.

Authors:  Kai-Hui Sun; Yolanda de Pablo; Fabien Vincent; Emmanuel O Johnson; Angela K Chavers; Kavita Shah
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.